LIPO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 32.11%

Insider Buying (Last 12 Months): $31,300.00

Insider Selling (Last 12 Months): $0.00

Lipella Pharmaceuticals Insider Trading History Chart

Lipella Pharmaceuticals Share Price & Price History

^$2.15

▼ -0.04 (-1.83%)

As of 03/14/2025 04:58 PM ET

Days: 30 | 90 | 365

Lipella Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2024	Jonathan H Kaufman	Insider	Buy	1,250	$6.08	$7,600.00	112,356
3/18/2024	Jonathan H Kaufman	Insider	Buy	3,750	$6.32	$23,700.00	107,981

SEC Filings (Institutional Ownership Changes) for Lipella Pharmaceuticals (NASDAQ:LIPO)

74.31% of Lipella Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Lipella Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
2/11/2025	Virtu Financial LLC	13,310	$41K	0.0%	N/A	1.100%

Data available starting January 2016

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Today's Range

Now: $2.15

$2.03

$2.25

50 Day Range

MA: $3.01

$2.15

$4.65

52 Week Range

Now: $2.15

$2.02

$12.00

Volume

77,575 shs

Average Volume

2,748,654 shs

Market Capitalization

$2.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of Lipella Pharmaceuticals?: Lipella Pharmaceuticals' top insider shareholders include:
Jonathan H Kaufman (Insider)
Learn More about top insider investors at Lipella Pharmaceuticals.
Who are the major institutional investors of Lipella Pharmaceuticals?: Lipella Pharmaceuticals' top institutional shareholders include:
Virtu Financial LLC — 1.10%
Learn More about top institutional investors of Lipella Pharmaceuticals stock.
Which major investors are buying Lipella Pharmaceuticals stock?: Within the previous quarter, LIPO stock was purchased by institutional investors including:
Virtu Financial LLC